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Abstract 
Fusion of HIV-1 with the membrane of its target cell, an obligate first step in virus infectivity, is 
mediated by binding of the viral envelope (Env) spike protein to its receptors, CD4 and 
CCR5/CXCR4, on the cell surface. The process of viral fusion appears to be fast compared with 
viral egress and has not been visualized by electron microscopy (EM). To capture fusion events 
for EM, the process must be slowed or stopped by trapping Env-receptor binding at an 
intermediate stage. Here we describe using fusion inhibitors to trap HIV-1 virions attached to 
target cells by Envs in an extended pre-hairpin intermediate state. Electron tomography revealed 
HIV-1 virions bound to TZM-bl cells by 2-4 narrow spokes, with slightly more spokes present when 
evaluated with mutant virions that lacked the Env cytoplasmic tail. These results represent the 
first direct visualization of the hypothesized pre-hairpin intermediate and improve our 
understanding of Env-mediated HIV-1 fusion and infection of host cells. 
 
Introduction 
The first step of HIV-1 entry into a host target cell, fusion between the viral and target cell 
membranes, is mediated by the viral envelope spike protein (Env). HIV-1 Env is a trimeric 
glycoprotein comprising three gp120 subunits that contain host receptor binding sites and three 
gp41 subunits that include the fusion peptide and membrane-spanning regions. Binding of the 
primary receptor CD4 to gp120 triggers conformational changes that expose a binding site for 
co-receptor (CCR5 or CXCR4). Coreceptor binding results in further conformational changes 
within gp41 that promote release of the hydrophobic fusion peptide, its insertion into the host 
cell membrane, and subsequent fusion of the host cell and viral membrane bilayers [1].  
 
Structural studies relevant to understanding Env-mediated membrane fusion include X-ray and 
single-particle cryo-EM structures of soluble native-like Env trimers in the closed (pre-fusion) 
conformation [2], CD4-bound open trimers in which the co-receptor binding site on the third 
hypervariable loop (V3) of gp120 is exposed by V1V2 loop rearrangement [3-6], a gp120 
monomeric core-CD4-CCR5 complex [7], and a post-fusion gp41 six-helical bundle formed by 
an a-helical trimeric coiled coil from the gp41 N-trimer region surrounded by three helices from 
the C-peptide region [8, 9] (Figure 1a). Prior to membrane fusion and formation of the post-
fusion gp41 helical bundle, the viral and host cell membranes are hypothesized to be linked by 
an extended pre-hairpin intermediate in which insertion of the gp41 fusion peptide into the host 
cell membrane exposes the N-trimer (HR1) region of gp41 [10]. Formation of the six-helical 
bundle and subsequent fusion can be inhibited by targeting the N-trimer region with C-peptide-
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based inhibitors; e.g., the fusion inhibitor T20 (enfuvirtide [Fuzeon]) [11], T1249, a more potent 
derivative of T20 [12], and a highly potent trimeric D-peptide (CPT31) [13], or with anti-gp41 
antibodies such as D5 [14] (Figure 1a).  
 
Visualizing the pre-hairpin intermediate that joins the host and viral membranes has not been 
straightforward. Despite 3-D imaging by electron tomography (ET) of HIV-1 infection of cultured 
cells [15-18] and tissues [19-22], viruses caught in the act of fusion have not been 
unambiguously found. In our ET imaging of HIV-1–infected humanized mouse tissues, we have 
identified hundreds of budding virions at various stages of egress and thousands of free mature 
and immature virions [19-22], but not a single example of a virus attached to a host cell via a 
pre-hairpin intermediate or in the process of fusing its membrane with the target cell membrane. 
The absence of observed viral fusion events might be explained if fusion is a fast process 
compared with viral budding; thus when cells or tissues are immobilized for EM or ET, the 
relatively slow process of viral budding would be more easily captured compared with the faster 
process of fusion. We assume that fusion could theoretically be observed if a virus were caught 
at exactly the right time, but this might require examining thousands or millions of images.  
 
Here we report visualizing the pre-hairpin intermediate by ET after treatment of HIV-1–exposed 
target cells with inhibitors of six-helix bundle formation that bind the N-trimer region of gp41 that 
is exposed during the fusion process. Using optimally preserved samples for ET with a nominal 
resolution ~7 nm, we found >100 examples of HIV-1 virions linked to TZM-bl target cells by 2-4 
narrow rods of density (spokes) in inhibitor-treated samples, but none in untreated or control-
treated samples. The approximate dimensions of the majority of the spokes matched models of 
gp41-only pre-hairpin intermediates in which the Env gp120 subunit had been shed. The 
average number of observed spokes connecting a virion to a target cell increased slightly when 
using a virus containing an Env with a cytoplasmic tail deletion, suggesting that the increased 
lateral mobility of cytoplasmic tail-deleted Envs in the viral membrane [23, 24] allowed more 
Envs to join the interaction with the target cell. We discuss the implications of these studies for 
understanding HIV-1 Env-mediated membrane fusion and how these results differ from a 
previous ET study of the “entry claw” that is formed upon HIV-1 or SIV interactions with target 
cells [25]. 
 
 
Results 
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Experimental design. A previous study used ET to visualize HIV-1 and SIV virions in contact 
with target cells after promoting a temperature-arrested state [26] in which viruses can remain 
attached to cells prior to fusion [25]. For that study, target cells were incubated with virus at 4˚C 
to allow binding but not fusion, warmed to 37˚C, and then fixed after incubations ranging from 
15 min to 3 h [25]. At all time points after warming, viruses were found attached to target cells 
by a cluster of 5-7 “rods,” each ~100 Å long and ~100 Å wide. The fact that the attachment 
structure was not found when the viruses and target cells were incubated in the presence of 
C34, a gp41 N-trimer–targeting C-peptide inhibitor related to T20 [25], suggests that the rod 
structure that was trapped during the temperature-arrested state did not involve the pre-hairpin 
intermediate.  
 
We hypothesized that addition of an HIV-1 fusion inhibitor that binds to the exposed gp41 N-
trimer after host cell receptor and coreceptor binding would slow or stop virus-host cell 
membrane fusion such that we could visualize pre-hairpin intermediate structures by ET (Figure 
1b). In addition, incubating with a fusion inhibitor at 37˚C obviated the need for a 4˚C incubation 
of virus and target cells, which we reasoned was desirable since low temperatures alter 
membrane fluidity [27-29], which could affect one or more steps in membrane fusion. Since 
target cells for HIV-1 are several microns in height, much thicker than the 0.5-1 µm limit for cryo-
ET [30], we used stained, plastic-embedded samples that could be cut into 300-400 nm sections 
using a microtome, and then examined the samples in 3-D using ET. Furthermore, because 
attached virions were rare, it was an advantage that radiation damage is minimal in plastic 
sections [31], thus more cells could be assayed in plastic sections than in samples prepared by 
cryo-ET methods (e.g., by examining thin leading edges of cells or using focused-ion-beam 
milling [32] to prepare a sufficiently thin sample), thus allowing for statistically-significant 
observations of virion attachment events. We prepared samples by light fixation followed by 
high-pressure freezing/freeze substitution fixation (HPF-FSF) instead of the traditional chemical 
fixation protocol used previously [25] because HPF vitrifies cells at ~10,000°/sec, stopping all 
cellular movement within msec and allowing optimal preservation of ultrastructural features [33-
36]. By contrast, chemical fixation immobilizes elements in the cell at different rates, and 
movement and rearrangement of transmembrane proteins may continue even in the presence 
of aldehyde fixatives [37-39]. Following HPF-FSF, samples were plastic embedded and stained 
with uranyl acetate and lead citrate as described in our previous ET studies of HIV-1 in infected 
tissues [20-22]. Since biosafety requirements for the current study necessitated the use of HIV-1 
pseudoviruses instead of infectious HIV-1, we verified that the ultrastructure of HIV-1 
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pseudoviruses, including approximate numbers and dimensions of Env trimer spikes and the 
presence of collapsed (in mature virions) versus C-shaped (in immature virions) cores [15, 40-
42], was preserved during the fixation, embedding, and staining procedures (Supplementary 
Figure 1), consistent with our previous publications involving ET of infectious HIV-1 in tissue 
samples [20-22]. These results are also consistent with previous direct comparisons of 
tomograms of stained and plastic-embedded versus unstained and cryopreserved SIV virions 
[25]. 
 
We characterized three fusion inhibitors of different sizes and potencies that target the exposed 
gp41 N-trimer region of the pre-hairpin intermediate for attempts to visualize the pre-hairpin 
intermediate: T1249-Fc, a C-peptide–based inhibitor that we linked to human Fc (MW = 65 
kDa), D5 IgG (MW = 150 kDa) [14], and CPT31, a high-affinity D-peptide inhibitor linked to 
cholesterol (MW = 9 kDa) [13, 43] (Figure 1a; Supplementary Figure 2a). We measured their 
neutralization potencies using in vitro HIV-1 pseudovirus neutralization assays [44] against the 
SC4226618 and 6535 viral strinas. We found potencies ranging from 50% inhibitory 
concentration (IC50) values of ~0.13 ng/mL for CPT31 to ≥40 µg/mL for D5 IgG (Supplementary 
Figure 2a). T1249-Fc exhibited intermediate potencies (IC50s = 0.99 µg/mL; 17 µg/mL) 
(Supplementary Figure 2a), higher than IC50s measured for T1249 peptide alone, consistent 
with limited steric accessibility resulting in decreased potencies for larger fusion inhibitors [45].  
 
We conducted ET experiments by first incubating TZM-bl cells, a HeLa cell line that stably 
expresses high levels of human CD4 and coreceptors CCR5 and CXCR4 [46], with 130 µg/mL 
of inhibitor (either T1249-Fc, D5, or CPT31) and ~5000 TCID50/mL of HIV-1 pseudovirus at 37˚C 
for 2, 4, or 48 hours, followed by HPF, FSF, plastic embedding, sectioning, and visualization by 
ET. In order to verify that results were not dependent upon a particular viral strain, we 
conducted experiments using pseudoviruses derived from two primary isolate HIV-1 strains: 
SC4226618 (Tier 2) and 6535 (Tier 1B) [47], chosen for their sensitivity to the fusion inhibitors 
(Supplementary Figure 2a) and because we had both wild-type and Env cytoplasmic tail-deleted 
forms of the 6535 pseudovirus. To identify attached virions by EM (Figure 2, Supplementary 
Figure 3), the peripheries of TZM-bl cells were scanned to locate roughly spherical objects with 
diameters ~100 nm that were near a cell surface. Regions of interest were then examined at 
higher magnification and at tilts of 0˚, 35˚ and -35° to verify that the objects were spherical, as 
expected for an HIV-1 virion. Potential virions were then observed through a defocus series to 
detect core structures found inside authentic virions: i.e., a bullet-shaped core in mature HIV-1 
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and a C-shaped core in immature HIV-1 [40, 42]. Once verified as a virion, tilt series for 3-D 
reconstructions were collected. Control experiments in which pseudovirus and TZM-bl cells 
were incubated without inhibitor, with an irrelevant IgG, or with a low concentration of inhibitor, 
were prepared and analyzed in the same way. 
 
TZM-bl cells are contaminated with ecotropic murine leukemia virus [48], which does not affect 
their use for HIV-1 in vitro neutralization assays [49]. In our surveys of TZM-bl cells incubated in 
the presence or absence of fusion inhibitors, we occasionally observed budding MLV virions 
(Supplementary Figure 4). As MLV serves as a control for non-specific inhibition in TZM-bl–
based HIV-1 in vitro neutralization assays [50], the fusion inhibitors used in our experiments are 
known to have no effect on MLV fusion, thus contaminating MLV virions were not captured 
during fusion in our experiments. 
 
Entry inhibitor-treated virions are attached to target cells by 2-3 narrow spokes. In 
surveys of TZM-bl cells treated with either SC4226618 or 6535 pseudovirus and 130 µg/mL of 
any of the three fusion inhibitors, we found virions that were attached to the surface of a TZM-bl 
cell by several (usually 2 or 3) narrow densities. To verify that the attached virions resulted from 
treatment with a fusion inhibitor, we analyzed control experiments in which we incubated TZM-bl 
cells and pseudovirus with either no inhibitor, with an irrelevant Fc-containing protein (Z004, an 
anti-Zika virus IgG [51]), or with the T1249-Fc inhibitor at a concentration equivalent to 0.01x of 
its neutralization potency (i.e., its IC50 value) (Supplementary Figure 2a). In examinations 
of >100 cells, we found no attached virions and also very few virions that were within a distance 
that could accommodate attachment. We used ET to examine the few cases (<20) in which we 
found virions adjacent to cells, which confirmed that none of the virions were attached to a host 
cell membrane (Supplementary Figure 5).  
 
The approximate dimensions of the densities found for virions attached to TZM-bl cells in the 
presence of a fusion inhibitor were 11-15 nm in length and ~2-4 nm in width (Figure 3), thus we 
refer to the densities as “spokes” to distinguish them from the wider densities described as 
“rods” in the previous ET study of virions attached to cells [25]. In some samples incubated with 
the largest inhibitor (D5 IgG), we occasionally found densities adjacent to one or more spokes 
that could represent the bound IgG (Figure 2d). We found virions attached with spokes to 10-
30% of TZM-bl cells that were examined, usually located on the thin leading edges of cells. 
Most cells showed only one attached virion per 400 nm section, but occasional cells exhibited 3-
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5 attached virions. The attachment sites were generally flat, as opposed to the target cell 
exhibiting a concave surface corresponding to the circumference of the virion as previously 
described [25], with distances of ~7 nm to ~15 nm between spokes. The majority of attached 
virions were mature, as identified by their bullet-shaped cores (Figures 2, 3), but a minor subset 
of attached virions (~5%) were immature. Figure 2 shows overview images and 2-D 
tomographic slices from 3-D reconstructions of fusion inhibitor-treated virions attached to target 
cells; see also a gallery of examples in Supplementary Figure 6. Attachment densities were 
sometimes located in different planes so they are not always visible in any given 2-D 
tomographic slice, thus we identified them in 3-D as shown in Supplementary Movie 1. 
 
Despite using inhibitors of different sizes and at concentrations varying from 3.2- to 106-fold 
above their IC50 values for neutralization of the SC4226618 pseudovirus (Supplementary Figure 
2a), we found no systematic differences in the numbers of attached virions per cell, their 
locations on TZM-bl cells, or the numbers and dimensions of spokes per attached virion. In 
addition, no systematic differences were observed as a function of which fusion inhibitor or 
pseudovirus was included in the incubation or the length of the 37˚C incubation (Figure 3d; 
Extended Data Table 1). Although a 48-hour incubation at 37˚C should result in a substantial 
loss of virus infectivity, the T1249-Fc incubation for 48 hours condition yielded an equivalent 
number of attached virions (Figure 3d) and similar spoke structures as the 2- and 4-hour 
incubations (Supplementary Figure 6). This finding is rationalized by calculations and infectivity 
measurements showing that the 48-hour incubation conditions contained several million 
infectious virions (Supplementary Figure 2b), enough to account for the observed attached 
virions. 
 
A cytoplasmic tail deletion virus forms attachment structures with more spokes. The 
finding of only 2-3 spokes per attached virion implies that not all of the ~14 Envs per HIV-1 
virion [52-56] are involved in the fusion process. Indeed, Env trimers that did not participate in 
attachment were sometimes observed in tomographic slices (Figure 4). We hypothesized that 
more Envs might join in the attachment site if we used a virus in which Envs could exhibit 
increased lateral mobility in the viral membrane to allow Env diffusion to the attachment site. 
Increased Env mobility in the viral membrane has been described in viruses with an Env 
cytoplasmic tail deletion that eliminates interactions with the viral matrix protein [23, 24]. To 
evaluate potential effects of increased lateral mobility, we used a pseudovirus containing an Env 
with a cytoplasmic tail deletion (6535-DCT) and compared its attachment sites with target cells 
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when incubated with the T1249-Fc fusion inhibitor to those of wild-type 6535 and SC4226618 
pseudoviruses when incubated under the same conditions (Figure 5).  
 
We first confirmed that attachment sites formed by wild-type 6535 and SC4226618 
pseudoviruses were indistinguishable in terms of their locations and numbers of observed 
spokes (Figure 3). We then gathered data for 6535-DCT attachment sites, finding a small, but 
statistically significant (p = 3 x 10-4) increase in the mean number of spokes: 3.9 +/- 1.2 (n = 15) 
spokes for 6535-DCT as compared to 2.4 +/- 0.6 (n = 116) spokes for wild-type pseudoviruses 
(Figures 3d, 5). 
 
Discussion 
Despite a wealth of information about the pre- and post-fusion structures of HIV-1 Env and 
Env’s interactions with host receptors [2-9, 54], the architecture of the virus-host cell contact and 
the structure of Env during the act of fusion have remained elusive. Because HIV-1 virions have 
not been visualized during the act of fusion, we assumed that viral fusion is a fast process that 
has yet to be captured by electron microscopy imaging of either cultured cells or tissues. In 
order to visualize the hypothesized pre-hairpin intermediate structure in which the gp41 
transmembrane region and the fusion peptide link the viral and target cell membranes [10], we 
incubated HIV-1 fusion inhibitors that bind to the N-trimer region of gp41 that is exposed upon 
Env binding to the host receptor and coreceptor on target cells. We chose to use diverse fusion 
inhibitors to trap the hypothesized pre-hairpin intermediate structure linking the viral and host 
cell membranes (Figure 1a) and to avoid a temperature jump protocol [25] that  
could result in unanticipated effects on membranes; for example, membrane trafficking events 
can be altered or stopped at decreased, non-physiological temperatures, and structures 
associated with them, such as Golgi cisternae, are perturbed and noticeably altered relative to 
physiological conditions [57]. 
 
We chose three fusion inhibitors with strong, medium, and weak neutralization potencies 
(CPT31, T1249-Fc, D5 IgG, respectively), incubated them at 37˚C with virus and target cells for 
variable times, and examined them in 3-D by ET. For all experimental conditions, we found 
virions linked to the surface of target cells by several (mean = 2.4 +/- 0.5; n = 116) narrow 
spokes (Figure 3d), thus all conditions contained sufficient numbers of virions and inhibitors to 
form stable attachments to target cells. By contrast, in control experiments with either no 
inhibitor, an irrelevant protein, or inhibitor added at a concentration equal to 1% of its 
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neutralization IC50 value, we did not observe virions attached to target cells. Based on current 
understanding of how fusion inhibitors prevent fusion [10, 58] (Figure 1a,b), we conclude that 
the attachment densities represent Env trimers in the pre-hairpin intermediate conformation that 
link viral and target cell membranes (Figure 1a). 
 
Having trapped virions in the act of fusion, we can use information gathered from tomograms to 
address mechanistic and structural details of fusion between viral and target cell membranes. 
First, the results suggest that only 2 to 3 (and occasionally 4) Envs participate in the reaction 
with target cells that is inhibited by a fusion inhibitor. This number represents a minority of the 
Env trimers on HIV-1, even considering that HIV-1 includes a unusually low number of spikes 
per virion: an average of ~14 with a range from 4 – 35 [52-56] (By comparison, similarly-sized 
influenza A virions contain ~450 spikes [59]). STED microscopy studies suggested that HIV-1 
spikes rearrange from a random distribution on immature virions to a cluster on mature virions 
[60, 61]. However, interspike distance distributions on mature virions derived from independent 
cryo-ET reconstructions revealed random spike distributions rather than a single cluster of 
spikes [53, 54]. Our finding of only 2-3 spokes per virion-target cell attachment site (Figure 3d 
Extended Data Table 1) is also consistent with random spike distributions on mature virions 
since more attachment spokes would be expected if Envs are clustered. In addition, although 
free Env trimers on HIV-1 virions are difficult to identify conclusively by ET using stained, 
plastic-embedded samples, we sometimes found Env spikes on the opposite surface of 
attached mature virions as the attachment structures (Figure 4c,d), consistent with the 
assumption that only two or three Envs are usually close enough to each other to participate in 
binding to host cell receptors and that slow lateral diffusion of HIV-1 Envs within the virion 
bilayer prohibits recruitment of additional Envs into the attachment structure.  
 
The ectodomains of Env trimers on immature virions are not expected to exhibit conformational 
changes that would prevent binding to CD4 and coreceptor. Indeed, immature virions can fuse 
with targets, although less efficiently than mature virions [62]. Consistent with Env trimers on 
immature virions binding to receptors on target cells and forming pre-hairpin intermediate 
structures, we occasionally found immature virions attached to target cells that were incubated 
with a fusion inhibitor. Immature virions comprised <5% of the datasets recorded. Attached 
immature virions exhibited comparable numbers and locations of spokes as we found for 
attached mature virions (Figure 4), consistent with a similar distribution of Envs on mature and 
immature virions. Although measurements of Env mobility within the membranes of mature and 
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immature virions differ, the HIV-1 viral membrane on both mature and immature virions is a low 
mobility environment, likely due to high lipid order [61]. Our results suggest that the intrinsically 
low mobilities of HIV-1 Envs on both mature and immature virions limit the number of Env 
trimers that can participate in pre-hairpin intermediate structures with target cells. 
 
The cytoplasmic tail of HIV-1 Env interacts directly with the viral matrix protein [63], and tail 
deletion has been suggested to increase the lateral mobility of Envs in the viral membrane [23, 
24]. In order to determine the effects of cytoplasmic tail deletion on virion attachment to a target 
cell in the presence of a fusion inhibitor, we used ET to compare attachment sites for virions 
with wild-type and cytoplasmic tail-deleted Envs. We found a slight, but statistically significant, 
increase for the number of spokes in attachment sites formed between fusion inhibitor-treated 
target cells and the 6535-DCT versus wild-type pseudoviruses (3.9 +/- 1.2 for 6535-DCT to 2.4 
+/- 0.5 for wild-type) (Figure 3d). These results are consistent with intrinsically low mobilities of 
HIV-1 Envs in the viral membrane that are increased only slightly for Envs that lack a 
cytoplasmic tail. Taken together, analyses of the numbers of apparent pre-hairpin intermediate 
structures trapped by fusion inhibitors on wild-type mature, wild-type immature, and cytoplasmic 
tail-deleted virions is consistent with the assumption that a minority of the relatively few HIV-1 
Env trimers are involved in attachment via a pre-hairpin intermediate to target cells. 
 
We also used the tomographic data to measure the dimensions at the virion-target cell 
attachment sites, finding that the approximate dimensions of the majority of the spokes (100-
150 Å in length x 20-35 Å in width) are consistent with a pre-hairpin intermediate structure 
formed by gp41 alone after gp120 has dissociated (step iv, Figure 1a), which we measured to 
be ~100 Å x ~22 Å (Figure 1b). By contrast, a hypothetical pre-hairpin intermediate containing 
gp120 (step iii, Figure 1a) would be wider, with dimensions ~100 Å by ~120 Å (Figure 1b). This 
wider structure is roughly consistent with the ~100 Å x ~100 Å dimensions of each of the 5-7 
rods of density that comprised the “entry claw” in a previous ET study [25]. We suggest that the 
entry claw rods visualized after incubating virus-target cell samples at 4˚C and then warming to 
37˚C represent a structure formed after the HIV-1 Env trimer has bound to CD4 (and possibly 
also to a coreceptor) but prior to gp120 dissociation. Given that entry claws were not visualized 
in the temperature jump protocol when the viruses and target cells were incubated in the 
presence of a fusion inhibitor [25], the rod structures are unlikely to represent a pre-hairpin 
intermediate. We therefore suggest that the rods likely correspond to a structure resembling 
step ii in Figure 1a.  
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A potential explanation for why we observe 2-3 densities at virion-target cell attachment sites 
versus the 5-7 reported previously [25] could relate to the observation that the attachment 
surfaces in our imaging experiments were generally flat, as opposed to including a concave 
surface on the target cell that followed the convex surface of the virion [25]. Thus if HIV-1 virions 
contain a random assortment of a small number of Env trimers that diffuse slowly or not at all in 
the membrane, then only a small number of Envs would be available on the small contact 
surface formed by a roughly spherical virion and a flat cell membrane, whereas more Envs 
would be available for contacts with a larger contact surface formed by a virion interacting with a 
concave cell membrane (Figure 1c). Indeed, a recent ET study of murine leukemia virus (MLV) 
attached to target cells revealed a concave surface on the target cell with ~28 spokes per 
attached virion [64], a number that would be predicted to be higher than observed for HIV-1 
even if HIV-1 were interacting with a concave portion of its target cell because MLV includes 
more spikes (at least 100 per virion) [65] compared with HIV-1 (7-14 per virion) [52-56]. 
 
In summary, we have used fusion inhibitors and ET of optimally preserved samples to visualize 
HIV-1 virions caught in the act of fusion with target cell membranes. These experiments 
revealed details of attachment sites with spokes representing pre-hairpin intermediate structures 
of HIV-1 Env. The spokes likely correspond to extended Env trimers after gp120 dissociation 
and prior to collapse into the post-fusion six-helical bundle structure (step iv in Figure 1a). Our 
observation of relatively few (2-3) spokes per attached virion implies that HIV-1 Env-mediated 
membrane fusion may require only a fraction of the ~14 Envs on each virion [52-56] and 
provides further details of an intermediate step on the pathway to viral entry. 
 
Methods 
 
Preparation of fusion inhibitors. A gene encoding T1249-Fc was constructed to encode the 
39-residue T1249 peptide sequence [12] fused at its C-terminus to a (Gly4Ser)7 linker followed 
by human IgG1 Fc. T1249-Fc were expressed by transient transfection in 293-6E (CNRC) or 
Expi293 (ThermoFisher Scientific) cells and purified from transfected cell supernatants using a 
HiTrap MabSelect SuRe column (GE Healthcare) followed by size exclusion chromatography 
(SEC) using a Superdex 200 column (GE Healthcare), and its concentration was determined by 
A280 nm measurements using an extinction coefficient of 129,550 M-1 cm-1. D5 IgG was obtained 
from the NIH AIDS Reagents program at a stock concentration of 8.5 mg/mL. CPT31 was 
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synthesized as described with its concentration measured by A280 (extinction coefficient of 
37,980 M-1 cm-1) [13]. Z004 IgG, an anti-Zika virus antibody used as a control for non-specific 
entry inhibition, was expressed and purified as described [51]. 
 
In vitro neutralization assays. SC4226618, 6535, and 6535-DCT (Env gene truncated after 
stop codon corresponding to gp41 residue Phe752) pseudoviruses were produced by 
cotransfection of HEK 293T cells with an Env expression plasmid and a replication-defective 
backbone plasmid [50]. In vitro neutralization assays were performed by measuring the 
reduction of HIV-1 Tat-induced luciferase reporter gene expression in the presence of a single 
round of pseudovirus infection in TZM-bl cells [50]. Inhibitors were evaluated using a 4-fold 
inhibitor dilution series (each concentration run in duplicate). Nonlinear regression analysis was 
used to derive IC50 and IC90 values, the concentrations at which half-maximal and 90% 
inhibition, respectively, were observed. 
 
 
Incubations for fusion inhibitor ET experiments. TZM-bl cells were plated and cultured as 
described [50] on carbon-coated, glow-discharged synthetic sapphire disks (3 mm diameter, 
0.05 mm thickness; Technotrade International). Briefly, ~50,000 to 70,000 cells in 1 mL were 
seeded in each well and then replaced after a day with fresh media containing DEAE-Dextran 
(12 µg/mL). T1249-Fc, CPT31, or D5 IgG fusion inhibitor, each at a concentration of 130 ug/mL, 
was combined with pseudovirus (either SC4226618, 6535, or 6535-DCT, each at ~5000 
TCID50/mL), and then immediately added to the cells and incubated for 2, 4, or 48 hours at 
37˚C. For control experiments, incubations were done with either no fusion inhibitor or with or 
with 130 µg/mL control IgG (Z004). In another control with SC4226618 pseudovirus, we added 
0.01 µg/mL T1249-Fc fusion inhibitor (a concentration corresponding to 100-fold lower than the 
IC50 value for T1249-Fc against SC4226618). For all incubations, supernatant was then 
removed from each well, and cells were lightly fixed with 3% glutaraldehyde, 1% 
paraformaldehyde, 5% sucrose in 0.1 M sodium cacodylate trihydrate to render the samples 
safe for use outside of BSL-2 containment. 
 
EM Preparation and Electron Tomography. Sapphire disks were rinsed briefly with 1-
Hexadecene (Sigma), placed individually into brass planchettes (Type A/B; Ted Pella, Inc.), and 
rapidly frozen with a HPM-010 High Pressure Freezing machine (BalTec/ABRA). Disks were 
transferred under liquid nitrogen to cryo-vials (Nunc) containing 2.5% OsO4, 0.05% uranyl 
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acetate in acetone and then placed in a AFS-2 freeze substitution machine (Leica 
Microsystems, Vienna). Samples were freeze substituted at -90°C for 72 h, warmed to -20°C 
over 12 h, held at that temperature for 24 h, and then warmed to room temperature and 
infiltrated with Epon-Araldite resin (Electron Microscopy Sciences, Port Washington, PA). 
Sapphire disks were flat-embedded on teflon-coated glass slides with Secure-Seal adhesive 
spacers (Sigma) and Thermanox plastic coverslips (Electron Microscopy Sciences). Resin was 
polymerized at 60°C for 24 h.  
 
Once embedded, the sapphire disks were removed, leaving the cells as a monolayer within the 
resin wafer. The cells were observed with an inverted phase-contrast microscope to ascertain 
preservation quality and to select regions of interest (i.e., regions with >10 cells in close 
proximity). These regions were extracted from the resin wafer with a microsurgical scalpel and 
glued to plastic sectioning stubs. Semi-thick (300-400 nm) serial sections were cut with a UC-6 
ultramicrotome (Leica Microsystems, Vienna) using a diamond knife (Diatome, Ltd., 
Switzerland). Sections were collected onto formvar-coated copper-rhodium 1 mm slot EM grids 
(Electron Microscopy Sciences) and stained with uranyl acetate and lead citrate. Colloidal gold 
particles (10 nm) were placed on both surfaces of the grid to serve as fiducial markers for 
subsequent tomographic image alignment. 
 
Grids were placed in a dual-axis tomography holder (Model 2040; E.A. Fischione Instruments, 
Export, PA) and imaged with a Tecnai TF-30ST transmission electron microscope (Thermo-
Fisher Scientific) operating at 300 keV. Images were recorded with a XP1000 CCD camera 
(Gatan, Inc.). For dual-axis tomography, grids were tilted +/- 64° and images taken at 1° 
intervals. The grid was then rotated 90° and a similar tilt-series was taken about the orthogonal 
axis. Tilt-series datasets were acquired automatically using the SerialEM software package [66]. 
Tomograms were calculated, analyzed and modeled (including isosurface renderings) using the 
IMOD software package [67-69] on Mac Pro and iMac Pro computers (Apple, Inc.).  
 
Identification and imaging of HIV-1 virions. Prior to collecting tomographic data, HIV-1 virions 
were identified as follows: Thick sections were observed in the electron microscope and 
peripheries of cells were surveyed at medium magnification (3900x – 6500x). Objects that 
appeared to be spherical, were estimated to have a diameter of ~100 nm, and were proximal to 
a cell surface were examined at higher magnification (12,000x – 15,000x). These objects were 
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observed at 0° tilt (perpendicular to the beam) and at +35° and -35° tilts to confirm that they 
were indeed spherical. Nonspherical objects, such as thin cellular projections or microspikes, 
would appear oblong or tubular at one or both high-tilt views. Objects that remained spherical 
were further evaluated by observing through a defocus series to detect core structures that 
would be indicative of a HIV-1 virion (i.e., a bullet-shaped mature core or a C-shaped immature 
core [40, 42]). Detection of core structures allowed the object to be classified as a HIV-1 
particle, and it was subsequently imaged for dual-axis tomography.	In most sample 
preparations, attached virions were found at an incidence of ~1 per every 5 cells in a given 400 
nm section. On rare occasions, several (2-3) virions were found attached to a single cell, and 
each virion was recorded as a separate dataset. Spoke counts were determined from 3-D 
tomographic reconstructions (Figure 3d; Extended Data Table 1). Significance evaluations of 
spoke count differences between 6535-DCT and wild-type pseudoviruses was performed using 
a two-sample t-test assuming unequal variances. 
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Figure 1 
 
 
 
Figure 1. HIV-1 Env-mediated fusion between viral and host cell membranes. a, Top: Schematics of 
host receptors, HIV-1 Env trimer, pre-hairpin intermediate, and fusion inhibitors. Bottom: steps in fusion: 
(i) Closed, prefusion structure of HIV-1 Env trimer in which the V1V2 loops (orange) occlude the 
coreceptor binding site on V3 (blue) (e.g., PDB code 5CEZ). The Env trimer is embedded in the viral 
membrane, while the host receptor (CD4) and coreceptor (CCR5) are embedded in the target cell 
membrane. (ii) CD4-bound open HIV-1 Env trimer in which V1V2 loops have been displaced to expose 
the coreceptor binding site on V3 (e.g., PDB 6U0L). (iii) Hypothetical CD4- and CCR5-bound open Env 
trimer with rearrangements of gp41 N-trimer/HR1 to form a pre-hairpin intermediate structure that is linked 
to the target cell membrane by the gp41 fusion peptide (red). (iv) Hypothetical pre-hairpin intermediate 
formed by gp41 trimer after shedding of gp120s. (v-vi) Formation of the post-fusion gp41 six-helical 
bundle (e.g., PDB 1GZL) that juxtaposes the host cell and viral membranes (step v) for subsequent 
membrane fusion (step vi). b, Approximate binding sites (red circles) for fusion inhibitors shown on 
schematics of steps iii and iv (panel a). Entry inhibitor binding sites might be partially sterically occluded 
for binding to the T1249-Fc or D5 fusion inhibitors. Schematics shown above as models are from PDB 
codes 6U0L and 1AIK with approximate dimensions indicated. c, Schematic illustrating why fewer HIV-1 
Envs might be involved in attaching to a target cell when the attachment site is flat versus a concave 
surface. Top: attachment site (described here) formed during a 37˚C incubation of virions, target cells, 
and a fusion inhibitor. Bottom: attachment site (described in [25]) formed in the absence of a fusion 
inhibitor when virions and target cells were incubated in a temperature jump protocol (4˚C incubation 
followed by warming to 37˚C). 
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Figure 2 
 
 
 
 
Figure 2. Identification of attached HIV-1 virions. a, Montaged projection overview of a field 
of cultured TZM-bl cells from a 400 nm section. Note extensive blebbing and surface projections 
that are typical of the cell type. Inset: Projection detail of a HIV-1 virion adjacent to TZM-bl cell 
surface. b, Slice (5.6 nm) from a tomographic reconstruction of the virion shown in the inset of 
panel a (from a dataset collected with the T1249-Fc inhibitor). The bullet-shaped core identifies 
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the particle as mature HIV-1 (see also Supplementary Figure 3). Two pre-hairpin intermediate 
“spokes” (red arrowheads) attach the virion to the cell surface. c, 3-D isosurface rendering of 
the spokes shown in panel b. d, Examples of extra densities observed in some data sets 
collected using the D5 IgG inhibitor. These appear as “hook-like” structures projecting from the 
sides of spokes, adjacent to the virion surface, which are visible in two sequential tomographic 
slices (small and large black arrows). Extra densities may represent portions of D5 IgGs 
attached to the prehairpin intermediate. Similar densities were not seen in experiments with the 
T1249-Fc or CPT31 inhibitors.   
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Figure 3 
 
 
 
 
Figure 3. Characteristics of virions attached to target cells in the presence of a fusion inhibitor. a, 
2-D projection image of TZM-bl cell incubated with SC4226618 pseudovirions in the presence of the 
T1249-Fc fusion inhibitor for 2 hours at 37˚C. Inset shows a tomographic slice of the attached virion 
indicated by a box with attachment spokes indicated by magenta arrowheads. b, 3-D model from 
tomogram of attachment site shown in panel a inset. c, Tomographic slice of attached virion from panel b 
with approximate measurements of spoke length, width, and inter-spoke distances. d, Summary of mean, 
standard deviation, and number of observations for spokes at attachment sites under different 
experimental conditions. See also gallery of images in Supplementary Figure 6. 
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Figure 4 
 
 
 
 
 
Figure 4. Free Env trimers can be visualized on attached virions. a, Example of densities 
observed for free HIV-1 Env trimers in a tomographic slice. b, 3-D isosurface rendering of an 
individual free Env trimer. c-d, Examples of attached mature (panel c) and immature (panel d) 
virions with free Env spikes distant from the attachment site indicated by arrows. Note that free 
Env trimer densities and spokes at an attachment site were only rarely optimally visualized in a 
single tomographic slice, thus Env trimers and spokes were identified from 3-D tomograms 
rather than 2-D tomographic slices.  
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Figure 5 
 
 
 
Figure 5. 6535DCT pseudoviruses are often attached to target cells with more than 2-3 
spokes. An example shows a 6535DCT virion attached to the plasma membrane of a TZM-bl 
cell (cell and virus were treated with the T1249-Fc fusion inhibitor for 2 hours). Viewing the 
tomogram in a series of slices through the reconstruction (left panels) reveals 5 distinct spokes 
(magenta arrowheads) at different positions on the virus’ surface. 3-D model of the 
reconstruction (right) displays the 5 spokes (magenta) attaching the virion (green) to the TZM-bl 
plasma membrane (PM) (blue). 
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Supplementary Figure 1 
 
 
Supplementary Figure 1. Identification of free pseudovirions in tomographic 
reconstructions. Virions were identified by visualizing a cone-shaped core structure in mature 
virions (upper left) and a C-shaped core structure in immature virions (lower left) and Env spikes 
on virion surfaces. Modeled contours highlight the core (blue) and Envs (black) in the mature 
virion (upper right) and in the immature virion (lower right). 
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Supplementary Figure 2 
 
 
 
Supplementary Figure 2. Characterization of fusion inhibitors and viral infectivity.  
a, Entry inhibitors are listed with their molecular weights, IC50 and IC90 values for neutralization 
potencies against SC4226618 and 6535 (and for T1249-Fc, also against 6535-DCT), and the 
fold above these values that they were used for fusion inhibitor imaging experiments in which 
the inhibitors were incubated at 130 µg/mL. N.N. = non-neutralizing. N/A = not applicable. b, 
Infectivity of SC4226618 pseudovirus after incubation with TZM-bl target cells for the indicated 
times at 37˚C. Luciferase activity (measured in relative luminescence units, RLUs) of 
supernatants transferred to fresh TZM-bl cells after the following incubation times is presented 
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as the mean and standard deviation for eight replicate measurements. ~20% of the input 
pseudovirus remained infectious after 48 hours at 37˚C. To address whether infectious 
pseudovirus was still present after a 48-hour incubation at 37˚C with T1249-Fc inhibitor and 
TZM-bl cells, we calculated how many molecules of T1249-Fc were added (1015 molecules) in 
the inhibition experiments, how many TZM-bl cells were cultured (~50,000 cells in each well, 
which contained 1 or 2 sapphire disks (3 mm each)), and how many SC4226618 pseudoviruses 
were added at the start of the incubation (2500 TCID50 = ~107 particles). Thus there were ~2 x 
106 infectious viruses, ~1015 molecules of T1249-Fc, and ~50,000 TZM-bl cells that were 
available for formation of spoke structures that could be captured by HPF and visualized by ET 
after the 48-hour incubation at 37˚C.  
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Supplementary Figure 3 
 
 
 
 
 
Supplementary Figure 3: Locating and identifying attached virions prior to electron 
tomography. a, Overview of a TZM-bl cell in a 400 nm section. To find virions, the peripheries 
of cells are scanned at low magnification (2,600x – 5,600x) to identify structures that appear 
spherical, ~100 nm in diameter and proximal to the cell’s plasma membrane. Two candidate 
objects are indicated by the square. b, Tilted projection views of candidate objects. Once 
candidates are located, they are observed at high magnification (12,000x – 15,000x) first at 0° 
(view perpendicular to the electron beam) and then at +/-35°. Virions maintain a spherical 
appearance at both tilted views, while non-viral objects (e.g., blebs and other cellular 
extensions) appear tubular or oblong in the high tilted view. c, Projection image of a candidate 
virion at -5 µm defocus. Candidate objects are further examined at high magnification through a 
defocus series in order to distinguish core structures (a cone-shaped core in mature virions or a 
C-shaped core in immature virions). Objects with a distinguishable core (arrowhead) were 
classified as virions and imaged by dual-axis tomography. d, 5.5 nm slice from a tomographic 
reconstruction of the virion in panel c.  
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Supplementary Figure 4 
 
 
 
 
 
 
Supplementary Figure 4. TZM-bl cells are contaminated with ecotropic murine leukemia 
virus. Two examples of nascent MLV particles emerging from the cell surface (top) and a 
cellular projection (bottom). Left panels show overviews of the cell with the locations of MLV 
budding events indicated by black rectangles. Right panels show tomographic details of the 
MLV budding profiles. 
  
.CC-BY-NC-ND 4.0 International licensewas not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprint (whichthis version posted April 30, 2020. . https://doi.org/10.1101/2020.04.29.068775doi: bioRxiv preprint 
	 26	
Supplementary Figure 5  
 
 
 
Supplementary Figure 5. Control experiments showed no attached virions. No virions 
were found attached to cell surfaces when TZM-bl cells and pseudoviruses were incubated at 
37˚C with either no inhibitor, with an irrelevant Fc-containing protein (Z004, an anti-Zika virus 
IgG [51]), or with the T1249-Fc inhibitor at a concentration equivalent to 0.01x of its 
neutralization potency (i.e., its IC50 value). Very few free virions were present in the samples 
with fewer still in proximity to cells (<1 particle per ~10 cells per section). In the above typical 
example from a control experiment, a single free virion was found near a TZM-bl cell in a 400 
nm section. Tomography (inset) revealed the virion to be too distant from the cell for attachment 
to occur and no structures resembling spokes on either the virion or the cell surface. 
 
 
 
  
.CC-BY-NC-ND 4.0 International licensewas not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprint (whichthis version posted April 30, 2020. . https://doi.org/10.1101/2020.04.29.068775doi: bioRxiv preprint 
	 27	
Supplementary Figure 6 
 
 
 
 
Supplementary Figure 6. Gallery of attachment sites formed using different fusion 
inhibitors and different incubation times. In examples shown here, attachments consisted of 
either two or three spokes (red arrowheads) linking virions to cell surfaces. All scale bars = 0.05 
µm. 
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Supplementary Movie 
 
Tomographic reconstruction of a mature HIV-1 pseudovirus (SC4226618) attached to a TZM-bl 
cell surface by two narrow spokes in an experiment in which the T1249-Fc inhibitor was 
incubated with cells and virus at 37˚C for 2 hours. The movie presents the full volume of a 3-D 
reconstruction, advances at 1-pixel (0.5 nm) increments, and then pauses briefly to indicate the 
spokes (red arrowheads). The cone-shaped viral core is distinguished within the virion, as are 
Env trimers on the virion surface. Scale bar = 0.05 µm. 
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Sample Average St. Dev. Count
WT6535+T1249-Fc (2 Hr) 2.64 0.74 14
CTD6535+T1249-Fc (2 Hr) 3.87 1.19 15
SC4226618+T1249-Fc 1st Prep (48 Hr) 2.34 0.48 58
SC4226618+T1249-Fc 2nd Prep (4 Hr) 2.33 0.49 12
SC4226618+T1249-Fc 3rd Prep (2 Hr) 2.25 0.45 16
SC4226618+CPT31 3rd Prep (2 Hr) 2.60 0.52 10
SC4226618+D5Ab 3rd Prep (2 Hr) 2.83 0.75 6
Combination 1: All SC4226618 + inhibitor 2.38 0.51 102
Combination 2: All w/o CT 2.41 0.54 116
6535wt+T1249-Fc (2 Hr) 6535delCT+T1249-Fc (2 Hr) SC4226618+T1249-Fc 1st Prep (48 Hr) SC4226618+T1249-Fc 2nd Prep (4 Hr) SC4226618+T1249-Fc 3rd Prep (2 Hr) SC4226618+CPT31 3rd Prep (2 Hr) SC4226618+D5Ab 3rd Prep (2 Hr) Combination 1: All SC4226618 + inhibitor Combination 2: All w/o CTD
Mean 2.64 3.87 2.34 2.33 2.25 2.60 2.83 2.38 2.41
Standard Deviation 0.74 1.19 0.48 0.49 0.45 0.52 0.75 0.51 0.54
Count 14 15 58 12 16 10 6 102 116
Data: # Spokes 2 2 2 2 2 3 3
2 5 2 3 2 3 4
4 3 3 2 2 3 2
3 4 2 2 3 3 3
3 6 2 3 2 2 3
4 5 3 2 2 2 2
2 5 2 2 2 2
2 5 3 2 2 3
3 3 2 3 2 3
2 3 3 3 2 2
3 4 2 2 2
3 4 3 2 2
2 2 3 3
2 3 2 3
4 2 3
2 2
3
3
2
3
3
2
3
3
3
2
2
2
2
2
3
2
2
2
2
3
3
2
3
3
2
2
2
2
3
2
2
2
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2
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2
2
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t-Test: Two-Sample Assuming Unequal Variances
6535wt+T1249-Fc (2 Hr) 6535delCT+T1249-Fc (2 Hr)
Mean 2.64 3.87
Variance 0.55 1.41
Observations 14 15
Hypothesized Mean Difference 0
df 24
t Stat -3.3481
P(T<=t) one-tail 0.0013
t Critical one-tail 1.7109
P(T<=t) two-tail 0.0027
t Critical two-tail 2.0639
t-Test: Two-Sample Assuming Unequal Variances
WT6535+T1249-Fc (2 Hr) Comb. 1 SC422-inhibitor
Mean 2.64 2.38
Variance 0.55 0.26
Observations 14 102
Hypothesized Mean Difference 0
df 15
t Stat 1.2685
P(T<=t) one-tail 0.1120
t Critical one-tail 1.7531
P(T<=t) two-tail 0.2239
t Critical two-tail 2.1314
t-Test: Two-Sample Assuming Unequal Variances
6535delCT+T1249-Fc (2 Hr) Comb. 2  All w/o delCT
Mean 3.87 2.41
Variance 1.41 0.30
Observations 15 116
Hypothesized Mean Difference 0
df 15
t Stat 4.6763
P(T<=t) one-tail 0.0001
t Critical one-tail 1.7531
P(T<=t) two-tail 0.0003
t Critical two-tail 2.1314
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